FindTrial
Sign In

Evaluating the impact of presurgical pain medication Tapentadol on recovery after total laparoscopic hysterectomy

Effect of preemptive Tapentadol administration on postoperative recovery after total laparoscopic hysterectomy a randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105923
Enrollment
60
Registered
2026-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Tablet Tapentadol: Dose 50 mg per oral Frequency 1 dose 1 hour before the surgery Control Intervention1: Paracetamol: Iv 1 gram sos post surgery

Sponsors

Dr Krishna Soni
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA status class 1 or class 2 Elective laparoscopic total abdominal hysterectomy

Exclusion criteria

Exclusion criteria: Known allergy to Tapentadol Chronic opioid use Renal/ hepatic impairment Psychiatric illness interfering with consent or pain reporting Drugs that have interactions with Tapentadol

Design outcomes

Primary

MeasureTime frame
Decrease in post op rescue analgesia in first 24 hours assessed by VAS scoringTimepoint: Decrease in post op rescue analgesia in first 24 hours assessed by VAS scoring—

Secondary

MeasureTime frame
Total dose of paracetamol givenTimepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Archana KN

JSS medical college and hospital

drarchanakashi@gmail.com9845140637

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026